NEO
NeoGenomics, Inc.#42 · 2019EPBYearly return
+133%
Peak return
+139%
Max drawdown
-31%
ADR (20 days)
+3.0%
Base
29 days / -18.6%
Prior run
+13%
Breakout volume
2.8x
Pivot
$21.25
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker. Beleg: offizielles 8-K-Filing bei der SEC.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare NEO with the current market directly.